Antigen processing for presentation of peptide epitopes by major histocompatibility complex (MHC) class I molecules involves genes in the MHC class II region. Among these, PSFI and PSF2 encode subunits of a transporter, which presumably delivers cytosolic peptides across the endoplasmic reticulum membrane to class I molecules. This close functional relationship of the transporter and class I heavy chain genes and their linkage within the MHC raise the question of whether PSFI and PSF2, like most class I genes, are polymorphic. By single-strand conformation polymorphism analysis and DNA sequencing, a small number of amino acid sequence variants of both PSFl and PSF2 was identified in a panel of cell lines. This limited polymorphism may contribute to a higher degree of variability at the level of the functional transporter, in which different alleles of the PSFl and PSF2 subunits may be combined. A possible involvement of the PSF1 and PSF2 genes in susceptibility to MHC-associated diseases was examined in a preliminary assessment in patients with ankylosing spondylitis, insulin-dependent diabetes mellitus, or celiac disease.
ABSTRACT
Antigen processing for presentation of peptide epitopes by major histocompatibility complex (MHC) class I molecules involves genes in the MHC class II region. Among these, PSFI and PSF2 encode subunits of a transporter, which presumably delivers cytosolic peptides across the endoplasmic reticulum membrane to class I molecules. This close functional relationship of the transporter and class I heavy chain genes and their linkage within the MHC raise the question of whether PSFI and PSF2, like most class I genes, are polymorphic. By single-strand conformation polymorphism analysis and DNA sequencing, a small number of amino acid sequence variants of both PSFl and PSF2 was identified in a panel of cell lines. This limited polymorphism may contribute to a higher degree of variability at the level of the functional transporter, in which different alleles of the PSFl and PSF2 subunits may be combined. A possible involvement of the PSF1 and PSF2 genes in susceptibility to MHC-associated diseases was examined in a preliminary assessment in patients with ankylosing spondylitis, insulin-dependent diabetes mellitus, or celiac disease.
The human major histocompatibility complex (MHC) encodes the class I and class II families of glycoproteins that present peptides for immunorecognition by cytotoxic and helper T lymphocytes, respectively. Class I molecules bind peptides generated by degradation of intracellular proteins, and class II molecules mainly associate with peptides derived from endocytosed extracellular proteins (1) (2) (3) . The class I and probably also the class II antigen-processing pathways are controlled by genes in the MHC class II region (4) (5) (6) (7) (8) (9) . Two genes encode components of the proteasome complex, which degrades cytosolic proteins and might generate antigenic peptides (10) (11) (12) (13) (14) (15) (16) (17) . Two closely linked genes, PSF1 and PSF2, encode subunits of a transporter, which presumably translocates peptides into an exocytic compartment where they associate with class I molecules (6-8, 18, 19) . The location of these genes in the MHC in close linkage to the class I and class II gene families may suggest that they coevolved to optimize functional interactions. This hypothesis raises the question of whether the proteasome subunits and the transporter genes, like most class I and class II genes, are polymorphic. Although both proteasome subunits display electrophoretic polymorphism in the mouse at least (10) (11) (12) (13) 17) , it is unknown whether allelic variants of the transporter exist. If so, these variants might influence the selection of peptide epitopes presented by class I molecules.
Genetic variability of the putative peptide transporter could also be implicated in immunopathological disorders that are associated with the MHC. Of these, ankylosing spondylitis (AS) is strongly associated with class I HLA-B27 molecules, although most individuals positive for HLA-B27 are not affected (20, 21) . If HLA-B27 itself is the primary susceptibility factor, an involvement of additional genes related to the function of class I molecules, such as PSFJ and PSF2, would be plausible. In contrast to AS, most MHCdisease associations may be accounted for by certain alleles of class II genes (22) . Celiac disease correlates with DQB1*0201 and DQA1*0501 (23, 24) , and insulin-dependent diabetes mellitus (IDDM) is associated with specific amino acid residues at positions 57 of DQB1 and 52 of DQA1 (25) (26) (27) (28) (29) . These associations possibly indicate an involvement of particular DQap heterodimers in disease susceptibility.
However, some extended haplotypes with the DQA1 and DQB1 susceptibility alleles confer a higher risk than other haplotypes and may, therefore, contain additional predisposing genes (30, 31) . Because of their location near DQAJ and DQB1, PSFJ and PSF2 may provide genetic markers for identification of the disease-susceptibility genes on these extended haplotypes.
In this study, the variability of PSF1 and PSF2 was investigated by single-strand conformation polymorphism (SSCP) analysis (32) and DNA sequencing. Several amino acid variants were identified and examined in a preliminary assessment for their association with AS, IDDM, and celiac disease. (Fig. 1) . DNA inate the variant nucleotides within the amplified DNA segments from 37 unrelated HLA-typed healthy donors of Caucasian origin. The PSF1 and PSF2 variants were examined for associations with each other and with the class I HLA-A and -B and the class II DRB, DQA, DQB, and DPB alleles. Val-333 of PSF1B or PSF1C was significantly associated (P < 0.026) with Ile-379 ofPSF2C (7/37 samples). This allelic combination was present in both of the two individuals typed DRB1*0801, DQB1*0402 (uncorrected P = 0.03), and in the BM9 HTCL with this haplotype, possibly indicating that in these cases the transporter genes may be included in an extended haplotype. No other significant allelic association was identified, which is probably a result of the low resolution of the PSF1 and PSF2 markers and the limited size of the study.
Frequencies of PSF1 and PSF2 Variants in MHC-Associated Diseases. Among 22 HLA-B27+ AS patients, the frequencies of Val-333 and Gly-637 of PSF1 were decreased, whereas Ile-379 of PSF2 was increased by comparison with 23 HLA-B27+ controls (Table 4) . However, these deviations were not statistically significant.
Typing of 50 IDDM patients revealed a decrease of Ala-665 and Gln-687 of PSF2, paralleled by an increase of homozygous Thr-665 and stop 687 residues, as compared with random healthy controls (uncorrected P = 0.02, PF = 0.45). The PSF2B allele may, therefore, be negatively associated with IDDM. However, the present finding is preliminary and must be confirmed in a larger population and in haplotypematched controls to evaluate its actual significance.
In contrast to IDDM, in celiac disease patients the frequencies of PSF1 and PSF2 sequence variants showed no deviation from the control panel (Table 4 (37) . In PSF1, Asp-637 in the ATP-binding domain is alternative to a glycine residue, which is highly conserved among other eukaryotic transporters in this family, including PSF2 and homologs of PSF1 and PSF2 in rodents (38, 39) . In PSF2, a premature termination signal at codon 687 creates a truncated polypeptide chain lacking the C-terminal 17 amino acids of the full-length reference sequence. This alteration has no effect on the stability of the molecule, as indicated by immunochemical evidence (8) . Also, similar deletions of up to 23 amino acids in mdrl P-glycoprotein have no functional consequences (40) . The potential allelic complexity of the functional transporter exceeds the small number of the identified PSF1 and PSF2 alleles, as these proteins are associated in heterodimeric or heteromultimeric complexes. The three Table 4 . Frequencies of PSF1 and PSF2 variant amino acids in AS patients (HLA-B27+), healthy controls (HLA-B27+), random population samples, IDDM patients, and celiac disease patients
Ile-333/Ile-333 9 39 (38, 39) and may, therefore, not be subjected to strong functional constraints.
Peptide transporter polymorphism might influence the selection of peptides delivered to class I molecules, as suggested by observations of uncertain general relevance that T cell recognition of identical class I molecules may depend on MHC-linked genes. In the rat, recognition of the RTL.Aa class I molecule by alloreactive T cells is affected by the yet unidentified cim locus in the MHC class II region (41, 42) . Similarly, certain human alloreactive cytotoxic lymphocyte clones recognize HLA-B35 and -B44 only in the presence of an unknown MHC gene product (43) . This factor could be an allogeneic peptide or a polymorphic molecule involved in antigen processing, such as the putative peptide transporter.
The potential contribution of PSF1 and PSF2 variants to susceptibility to MHC-associated diseases was evaluated in small panels of AS, IDDM, and celiac disease patients and controls. There was no significant correlation of these markers with AS and celiac disease. In IDDM, a negative association was observed with the PSF2B allele, which must be tested in substantially larger panels to reach statistical significance. This association might suggest a contribution of transporter alleles to resistance and/or susceptibility to IDDM, although such an association may be only secondary to linkage disequilibrium with the DQ-DR region. In nonobese diabetic (NOD) mice, autoimmune diabetes may correlate with reduced surface expression of class I molecules associated with low levels of HAM1 (homologous to PSF1) mRNA and with a HAM1 restriction fragment length polymorphism. Similarly, expression of class I molecules is reduced in IDDM patients and in a high-risk group of prediabetics (44) . A possible correlation of this condition with low PSF1 expression has not been examined. However, our present data provide no substantial evidence that a PSF1 allelic variant could underlie susceptibility to IDDM.
